ClassID:

21647

A61K2300/00 - page 74 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#21901
20060147430
2006-07-06

Adipose-derived stem cells for tissue regeneration and wound healing

#21902
20060147428
2006-07-06

Allogeneic and xenogeneic transplantation

#21903
20060147423
2006-07-06

Transungual device

#21904
20060147420
2006-07-06

Oncolytic adenovirus armed with therapeutic genes

#21905
20060147418
2006-07-06

Recombinant double-stranded RNA phages and uses thereof

#21906
20060147416
2006-07-06

Method for the treatment of myelodysplastic syndromes using cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-OXO-2,3-dihydro-1 H-isoindol-4-yl}-amide

#21907
20060147405
2006-07-06

Method for treating urushiol induced contact dermatitis

#21908
20060147401
2006-07-06

Skin material for external use and antiprutiric agent for external use and wrinkle-instrument using the same

#21909
20060147391
2006-07-06

Composition for enhancing oral health

#21910
20060147385
2006-07-06

Nasal spray steroid formulation and method

#21911
20060147384
2006-07-06

Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)

#21912
20060147382
2006-07-06

Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases

#21913
20060142685
2006-06-29

Fluid wound dressing comprising partially cured polyurethane

#21914
20060142397
2006-06-29

Use of a pparalpha agonist and metormin for decreasing the serum triglycerides

#21915
20060142394
2006-06-29

Use of proteases for decomposing allergens

#21916
20060142386
2006-06-29

Bis(thio-hydrazide amides) for increasing Hsp70 expression

#21917
20060142382
2006-06-29

Skin lightening composition

#21918
20060142373
2006-06-29

Medicaments for the Treatment or Prevention of Fibrotic Diseases

#21919
20060142358
2006-06-29

Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes

#21920
20060142344
2006-06-29

Method for treating HIV infection through co-administration of tipranavir and GW695634

#21921
20060142338
2006-06-29

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

#21922
20060142316
2006-06-29

Combination therapy

#21923
20060142308
2006-06-29

Synergistic combination comprising roflumilast and formoterol

#21924
20060142297
2006-06-29

Combination product of inhibitor of the src family of non-recetpor tyrosine kinases and gemcitabine

#21925
20060142290
2006-06-29

Compositions for affecting weight loss

#21926
20060142288
2006-06-29

Combinations and methods for headaches

#21927
20060142287
2006-06-29

Use of a combination of dppe with other chemotherapeutic agents for the treatment of breast cancer

#21928
20060142282
2006-06-29

Combination effective for the treatment of impotence

#21929
20060142273
2006-06-29

Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine

#21930
20060142265
2006-06-29

Compositions comprising multiple bioactive agents, and methods of using the same

#21931
20060142256
2006-06-29

Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis

#21932
20060142255
2006-06-29

Hypocholesteremic preparations containing phytostenolesters of conjugated fatty acids, and methods of reducing serum cholesterol levels using the same

#21933
20060142251
2006-06-29

Anti-microbial agents derived from methionine sulfoximine analogues

#21934
20060142248
2006-06-29

Xanthurenic acid derivative pharmaceutical compositions and methods related thereto

#21935
20060142239
2006-06-29

Potassium or sodium salt of (-)-2-(4-hydroxyphenyl)ethyl!-thio-3-'4-{4-'(methzlsulfonzl)oxy !phenoxy}phenyl!propanoic acid and their use in medicine

#21936
20060142216
2006-06-29

Parasiticidal composition

#21937
20060142212
2006-06-29

Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer

#21938
20060142197
2006-06-29

TNF receptor and steroid hormone in a combined therapy

#21939
20060142186
2006-06-29

Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease

#21940
20060142180
2006-06-29

Cholinergic modulation of microglial activation via alpha-7 nicotinic receptors

#21941
20060142178
2006-06-29

Method of treating cancer

#21942
20060141082
2006-06-29

Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity

#21943
20060141081
2006-06-29

Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity

#21944
20060141080
2006-06-29

Bioavailability/bioefficacy enhancing activity of and extracts and fractions thereof

#21945
20060141079
2006-06-29

Supplement foods and pharmaceuticals

#21946
20060141078
2006-06-29

Composition comprising a rice protein hydrolysate and an agent for increasing glycosaminoglycan synthesis

#21947
20060141076
2006-06-29

Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase

#21948
20060141075
2006-06-29

Methods and compositions for weight management and mood enhancement

#21949
20060141071
2006-06-29

Compositions and methods for treating gynecological disorders

#21950
20060141070
2006-06-29

Notoginseng saponin intravenous injection and the method for preparing this injection

#21951
20060141069
2006-06-29

Synergistic antipyretic formulation

#21952
20060141068
2006-06-29

Herbal formulation as memory enhancer in Alzheimer condition

#21953
20060141067
2006-06-29

Anti-allergic herbal formulation

#21954
20060141066
2006-06-29

Herbal nutritious chocolate formulation and process for preparation thereof

#21955
20060141065
2006-06-29

Herbal formulation for the treatment of piles

#21956
20060141064
2006-06-29

Herbal formulation useful as local anesthetic

#21957
20060141063
2006-06-29

Health promoting functional foods fortified with herbs

#21958
20060141061
2006-06-29

Anti-arthritic herbal composition and method thereof

#21959
20060141059
2006-06-29

Self-preserved ophthalmic pharmaceutical compositions containing tobramycin

#21960
20060141058
2006-06-29

Methods and compositions for weight management and mood enhancement

#21961
20060141057
2006-06-29

Methods of treatment of inflammatory diseases

#21962
20060141056
2006-06-29

Antimicrobial resin composition

#21963
20060141039
2006-06-29

Oral compositions containing oxidized camellia

#21964
20060141033
2006-06-29

P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient

#21965
20060141024
2006-06-29

Synergistic combination kit of alpha,beta-arteether, sulfadoxin and pyrimethamine for treatment of severe/multi-drug resistant cerebral malaria

#21966
20060141023
2006-06-29

Pharmaceutical compositions containing abiguanide-glitazone combination

#21967
20060141017
2006-06-29

Zinc-based compositions and methods of use

#21968
20060140990
2006-06-29

Composition for topical treatment of mixed vaginal infections

#21969
20060140986
2006-06-29

Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine

#21970
20060140953
2006-06-29

Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor

#21971
20060140949
2006-06-29

Recombinant A2-specific TNFα-specific antibodies

#21972
20060140927
2006-06-29

Cytochrome P450 enzyme complexes and methods of treatment using the same

#21973
20060140925
2006-06-29

Composition of biochemical compounds involved in bioenergy metabolism of cells and method of use

#21974
20060140923
2006-06-29

Platelet gel comprising platelet-rich plasma, platelet activator and polymer

#21975
20060140916
2006-06-29

Methods and compositions for treating congestive heart failure

#21976
20060140915
2006-06-29

Veterinary protocol for cellular regeneration

#21977
20060140911
2006-06-29

Bacteriophage for the treatment of bacterial biofilms

#21978
20060140910
2006-06-29

Recombinant adenoviral vectors and methods of use

#21979
20060140885
2006-06-29

Method of reducing oral tissue inflammation using magnolia extract

#21980
20060140883
2006-06-29

Oral care compositions containing a eucalyptus extract

#21981
20060140876
2006-06-29

Buccal cavity treatment composition and corresponding uses thereof

#21982
20060140857
2006-06-29

Method of the administration of drugs with binding affinity for plasma protein and preparation to be used in the method

#21983
20060138257
2006-06-29

Incontinence treating sporting outfits

#21984
20060137702
2006-06-29

Anti-cigarette herbal formulation as an antidote to tobacco

#21985
20060135619
2006-06-22

Anthranilic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase 3

#21986
20060135610
2006-06-22

Cardiovascular compositions

#21987
20060135600
2006-06-22

Compositions for inhibition of necrosis induced by a neurotrophin

#21988
20060135599
2006-06-22

Use for pharmaceutical composition

#21989
20060135567
2006-06-22

Comprehensive pharmacologic therapy for treatment of obesity

#21990
20060135563
2006-06-22

Method for treating HIV infection through co-administration of tipranavir and SCH-417690

#21991
20060135562
2006-06-22

Method for treating HIV infection through co-administration of tipranavir and darunavir

#21992
20060135534
2006-06-22

Pyrazine based inhibitors of glycogen synthase kinase 3

#21993
20060135533
2006-06-22

Compound preparation for dizziness

#21994
20060135527
2006-06-22

Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (BCRP)-mediated resistance to therapeutic agents

#21995
20060135513
2006-06-22

Methods of treating tumors

#21996
20060135508
2006-06-22

Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them

#21997
20060135506
2006-06-22

Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders

#21998
20060135497
2006-06-22

Combination therapy for treating heart disease

#21999
20060135486
2006-06-22

Use of sulfonamide-including compounds in combination with angiogenesis inhibitors

#22000
20060135471
2006-06-22

Anti-obesity compositions

#22001
20060135468
2006-06-22

Treatment of refractory cancers using NA+/K+ ATPase inhibitors

#22002
20060135460
2006-06-22

Methods, assays and compositions for treating retinol-related diseases

#22003
20060135458
2006-06-22

Antiviral oligonucleotides

#22004
20060135446
2006-06-22

Composition for improving blood fluidity

#22005
20060135441
2006-06-22

Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors

#22006
20060135437
2006-06-22

Method for treating pain in trigeminal neuralgia

#22007
20060135435
2006-06-22

Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer

#22008
20060135430
2006-06-22

BLy antagonists and uses thereof

#22009
20060135421
2006-06-22

Unitary combination of FSH and hCG

#22010
20060135415
2006-06-22

Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier

#22011
20060135405
2006-06-22

Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments

#22012
20060135403
2006-06-22

Therapeutic formulations for the treatment of beta-amyloid related diseases

#22013
20060134646
2006-06-22

Method for treatment of HIV infection

#22014
20060134286
2006-06-22

Gallocatechin gallate-containing composition

#22015
20060134248
2006-06-22

Hop acids as a replacement for antibiotics in animal feed

#22016
20060134247
2006-06-22

Treatment of inflammatory bowel disease

#22017
20060134244
2006-06-22

Breast health supplement and detoxification preparations

#22018
20060134242
2006-06-22

Synergistic composition for the treatment of diabetes mellitus

#22019
20060134239
2006-06-22

Agents against microorganisms containing patchouli oil, patchouli alcohol and/or the derivatives thereof

#22020
20060134237
2006-06-22

Anti-microbial composition and methods of use thereof

#22021
20060134236
2006-06-22

Anti-allergy composition and related method

#22022
20060134235
2006-06-22

External preparation for improving blood flow

#22023
20060134234
2006-06-22

Cosmetic composition

#22024
20060134232
2006-06-22

Herbal supplement for cognitive related impairment due to estrogen loss

#22025
20060134231
2006-06-22

Use of natural plant extracts in cosmetic compositions

#22026
20060134230
2006-06-22

Weight loss composition and formulation

#22027
20060134227
2006-06-22

Compositions including iron

#22028
20060134226
2006-06-22

Compositions useful to treat ocular neovascular diseases and macular degeneration

#22029
20060134225
2006-06-22

Phosphate binder with reduced pill burden

#22030
20060134217
2006-06-22

Leukotriene and integrin inhibitor combination and treatment method

#22031
20060134207
2006-06-22

Dosage form containing diphenhydramine and another drug

#22032
20060134186
2006-06-22

Oxygenating agents for enhancing host responses to microbial infections

#22033
20060134171
2006-06-22

Agents which regulate, inhibit, or modulate the activity and/or expression of formyl peptide receptors as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies

#22034
20060134149
2006-06-22

Methods for treatment of inflammatory diseases

#22035
20060134127
2006-06-22

Antiallergic agent

#22036
20060134126
2006-06-22

Peptide constructs for treating disease

#22037
20060134117
2006-06-22

Preventives/remedies for cancer

#22038
20060134112
2006-06-22

Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17

#22039
20060134102
2006-06-22

Lymphotoxin beta receptor agents in combination with chemotherapeutic agents

#22040
20060134094
2006-06-22

FIBRIN MATERIAL AND METHOD FOR PRODUCING AND USING THE SAME

#22041
20060134093
2006-06-22

Fibrin cell supports and methods of use thereof

#22042
20060134091
2006-06-22

Additive for an animal feed

#22043
20060134088
2006-06-22

Enzymatic treatment of retinitis pigmentosis

#22044
20060134084
2006-06-22

Therapeutic platelets and methods

#22045
20060134081
2006-06-22

Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system

#22046
20060134075
2006-06-22

Composition and method for improving function of embryonic kidney transplants

#22047
20060134074
2006-06-22

Compositions and methods for promoting hair growth

#22048
20060134068
2006-06-22

Treatment of cancer by simultaneous inhibiton of BRAF and restoration or mimicry of p16INK4A activity

#22049
20060134064
2006-06-22

Combined treatment with interferon-alpha and an epidermal growth factor receptor kinase inhibitor

#22050
20060134060
2006-06-22

Ophthalmic compositions comprising Aloe Vera

#22051
20060134039
2006-06-22

Nail restructuring compositions for topical application

#22052
20060134031
2006-06-22

Phototherapy compositions and methods

#22053
20060134017
2006-06-22

Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound

#22054
20060134014
2006-06-22

Method to promote oral health in companion animals

#22055
20060134011
2006-06-22

Oral and dental composition

#22056
20060128810
2006-06-15

Remedies for allergic diseases

#22057
20060128809
2006-06-15

Rapidly absorbed liquid compositions

#22058
20060128808
2006-06-15

Method of using adapalene in acne maintenance therapy

#22059
20060128802
2006-06-15

Methods of treating tardive dyskinesia and other movement disorders

#22060
20060128800
2006-06-15

Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis

#22061
20060128792
2006-06-15

Deguelin as a chemopreventive agent for lung cancer

#22062
20060128762
2006-06-15

Medicinal composition and method for treating malignant tumor and utilization thereof

#22063
20060128751
2006-06-15

CETP inhibitors in combination with antihypertensive agents and uses thereof

#22064
20060128746
2006-06-15

Use of pagoclone for the treatment of social anxiety disorder

#22065
20060128742
2006-06-15

Cell migration inhibiting compositions and methods and compositions for treating cancer

#22066
20060128733
2006-06-15

Method for treating HIV infection through co-administration of tipranavir and reverset

#22067
20060128731
2006-06-15

Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists

#22068
20060128730
2006-06-15

Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders

#22069
20060128721
2006-06-15

Novel formulations of opioid-based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives

#22070
20060128716
2006-06-15

Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

#22071
20060128714
2006-06-15

Maternal multi-nutrient against diabetes-related birth defects

#22072
20060128694
2006-06-15

Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders

#22073
20060128687
2006-06-15

Lactam glycogen phosphorylase inhibitors and method of use

#22074
20060128681
2006-06-15

Novel rho inhibitors

#22075
20060128679
2006-06-15

Method for treatment of dysmenorrhea

#22076
20060128676
2006-06-15

Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain

#22077
20060128675
2006-06-15

Method for monitoring the effectiveness of teracycline in the treatment of asthma

#22078
20060128674
2006-06-15

Intermediates for imidazonaphthyridines

#22079
20060128673
2006-06-15

Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditions

#22080
20060128672
2006-06-15

Methods for the administration of amifostine and related compounds

#22081
20060128671
2006-06-15

Compositions containing a combination of a creatine compound and a second agent

#22082
20060128657
2006-06-15

Selected betaines and their uses

#22083
20060128656
2006-06-15

Charged phospholipid compositions and methods for their use

#22084
20060128655
2006-06-15

Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents

#22085
20060128653
2006-06-15

Pharmaceutical formulation of decitabine

#22086
20060128651
2006-06-15

Methods and compositions for modulating drug activity through telomere damage

#22087
20060128640
2006-06-15

Combination of a taxane and a cyclin-dependent kinase

#22088
20060128625
2006-06-15

Povidone-containing carriers for polypeptide growth factors

#22089
20060128624
2006-06-15

Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration

#22090
20060128611
2006-06-15

Composition for enzyme inhibition

#22091
20060128587
2006-06-15

Lipase-containing composition and methods of use thereof

#22092
20060127917
2006-06-15

Comprehensive virus disinfecting strategy and methods for making a preventive anti-virus medical product

#22093
20060127895
2006-06-15

Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer

#22094
20060127560
2006-06-15

Protein-containing preparation which can be biotechnologically produced, method for the production thereof, and use of the same as a food ingredient

#22095
20060127517
2006-06-15

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#22096
20060127515
2006-06-15

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#22097
20060127514
2006-06-15

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#22098
20060127513
2006-06-15

Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response

#22099
20060127508
2006-06-15

Preparation for the relief of disease

#22100
20060127507
2006-06-15

Agent for increasing granulocyte macrophage colony stimulating factor

#22101
20060127506
2006-06-15

Compositions of S-adenosyl-L-methionine

#22102
20060127505
2006-06-15

Anti-inflammatory formulations

#22103
20060127504
2006-06-15

Medicament for treatment of cancer and other diseases

#22104
20060127503
2006-06-15

Compositions for treatment of inflammatory diseases

#22105
20060127502
2006-06-15

Methods for inhibiting STAT3 signaling in immune cells

#22106
20060127497
2006-06-15

Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide

#22107
20060127496
2006-06-15

L-histidine in ophthalmic solutions

#22108
20060127493
2006-06-15

Composition for treating psoriasis

#22109
20060127492
2006-06-15

Sustained improver of muscular fatigue

#22110
20060127488
2006-06-15

Process of making flowable hemostatic compositions and devices containing such compositions

#22111
20060127482
2006-06-15

Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases

#22112
20060127468
2006-06-15

Methods and related compositions for reduction of fat and skin tightening

#22113
20060127462
2006-06-15

Wound care device having fluid transfer properties

#22114
20060127452
2006-06-15

Method and composition for reducing cravings for a craved substance

#22115
20060127449
2006-06-15

Method and composition for lowering cholesterol

#22116
20060127445
2006-06-15

Anti-angiogenic compositions and methods of use

#22117
20060127440
2006-06-15

Drug delivery systems for the prevention and treatment of vascular diseases

#22118
20060127431
2006-06-15

Inhibition of mammalian hair growth

#22119
20060127430
2006-06-15

Controlled-Release of Cosmetic and Pharmaceutical Agents via Osmotic Nano-Diffusion from Zeolite Cage Complexes

#22120
20060127429
2006-06-15

Topical numbing composition for laser therapy

#22121
20060127387
2006-06-15

Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions

#22122
20060127373
2006-06-15

Use of substance P for mobilization of Mesenchymal stem cells or proliferation of Mesenchymal stem cells and for wound healing or facilitating wound healing

#22123
20060127367
2006-06-15

Compositions containing macrophages and uses thereof

#22124
20060127365
2006-06-15

Method of cell therapy using fused cell hybrids

#22125
20060127357
2006-06-15

Rapamycin and il-10 for the treatment of immune diseases

#22126
20060127330
2006-06-15

Composition for treating and/or preventing periodontal disease

#22127
20060127321
2006-06-15

Pharmaceutical foam

#22128
20060127315
2006-06-15

Methods of treating humans undergoing injection of a contrast agent

#22129
20060127307
2006-06-15

Devices and compositions containing boron and silicon for use in neutron capture therapy

#22130
20060122391
2006-06-08

Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

#22131
20060122275
2006-06-08

Agentfor reducing side effects of diclofenac

#22132
20060122273
2006-06-08

Use for deferiprone

#22133
20060122270
2006-06-08

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism

#22134
20060122220
2006-06-08

Method for treating HIV infection through co-administration of tipranavir and UK-427,857

#22135
20060122219
2006-06-08

Flumazenil for the treatment of cocaine dependency

#22136
20060122217
2006-06-08

Combination of organic compounds

#22137
20060122200
2006-06-08

Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies

#22138
20060122194
2006-06-08

Tablet comprising efletirizine and pseudoephedrine

#22139
20060122192
2006-06-08

Chemical compounds

#22140
20060122186
2006-06-08

Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia

#22141
20060122180
2006-06-08

Therapeutic treatment

#22142
20060122160
2006-06-08

Co-administration of dehydroepiandrosterone (DHEA) congener with parthenolide for treating inflammation

#22143
20060122159
2006-06-08

Pharmaceutical formulation

#22144
20060122158
2006-06-08

Pharmaceutical application of 15- or 16-substituted testosterone analogues

#22145
20060122151
2006-06-08

Composition containing an association of aspirin and an anti-Xa oligosaccharide and use of an anti-Xa oligosaccharide optionally in combination with aspirin

#22146
20060122149
2006-06-08

Extraction and purification method for cereal beta-glucan

#22147
20060122147
2006-06-08

Combination preparation of hyaluronic acid and at least oe local anesthetic and the use thereof

#22148
20060122127
2006-06-08

Methods for reducing the side effects associated with mirtzapine treatment

#22149
20060122115
2006-06-08

Use of SERP-1 as an antiplatelet agent

#22150
20060122110
2006-06-08

Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system

#22151
20060122106
2006-06-08

Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof

#22152
20060122105
2006-06-08

Method of improing the growth performance of an animal

#22153
20060122103
2006-06-08

Dalfopristine/quinupristine combinations with cefpirome

#22154
20060122095
2006-06-08

Mucus formulation for mucosal surfaces and uses thereof

#22155
20060121480
2006-06-08

Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome

#22156
20060121138
2006-06-08

Hepatocurative effect of Emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs

#22157
20060121133
2006-06-08

Antioxidant dietary supplement compositions and methods for maintaining healthy skin

#22158
20060121132
2006-06-08

TNF-alpha production inhibitor comprising kavalactone as an active ingredient

#22159
20060121131
2006-06-08

Pharmaceutical compositions comprising cereal beta (1-3) beta (1-4) glucan

#22160
20060121129
2006-06-08

Dietary supplement

#22161
20060121128
2006-06-08

Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms

#22162
20060121125
2006-06-08

Formulation which can be administered gastrointestinally, containing green tea extract and an no donor

#22163
20060121117
2006-06-08

Anti-angiogenic compositions and methods of use

#22164
20060121103
2006-06-08

Transdermal delivery system

#22165
20060121101
2006-06-08

Method for oxygen treatment of intact skin

#22166
20060121094
2006-06-08

Preparation comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals

#22167
20060121086
2006-06-08

Drug-eluting stents coated with non-nucleotide P2Yreceptor antagonist compound

#22168
20060121072
2006-06-08

Topical parasiticide formulations and methods of treatment

#22169
20060121046
2006-06-08

Compositions and methods for WT1 specific immunotherapy

#22170
20060121037
2006-06-08

Methods of treating rheumatoid arthritis with anti-TNF antibodies

#22171
20060121034
2006-06-08

Treatment for alzheimer's disease and related conditions

#22172
20060121029
2006-06-08

Method and composition for regulating the activity of regulatory t cells

#22173
20060121020
2006-06-08

Mixture preparation for enhancing absorption of immunoglobulins in postnatal domestic mammals, and the method thereof

#22174
20060121018
2006-06-08

Methods and compositions for targeting proteins across the blood brain barrier

#22175
20060121017
2006-06-08

Compositions and methods for treating pancreatic insufficiency

#22176
20060121016
2006-06-08

Methods and compositions for treatment of free radical injury

#22177
20060121007
2006-06-08

Combined regulation of neural cell production

#22178
20060121002
2006-06-08

Methods and compositions for tissue regeneration

#22179
20060120997
2006-06-08

Cancer therapeutic compositions

#22180
20060120996
2006-06-08

Vaccine immunotherapy for immune suppressed patients

#22181
20060120995
2006-06-08

Neoadjuvant genetic compositions and methods

#22182
20060120994
2006-06-08

Bioabsorbable polymers

#22183
20060120990
2006-06-08

Composition for treating hair and scalp and method for preparing same

#22184
20060120977
2006-06-08

Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues

#22185
20060120967
2006-06-08

Solution forms of cyclodextrins for nasal or throat delivery of essential oils

#22186
20060120966
2006-06-08

Salmeterol superfine formulation

#22187
20060116510
2006-06-01

Isoflavone concentrates, as well as methods for their production

#22188
20060116349
2006-06-01

Methods and compositions for administration of iron for the treatment of restless leg syndrome

#22189
20060116335
2006-06-01

Ready-for-complexation composition

#22190
20060116334
2006-06-01

Folate based composition for treatment of the cardiovascular system

#22191
20060116328
2006-06-01

Combined use of carnosinase inhibitor with l-carnosines and composition

#22192
20060115571
2006-06-01

Functional foods/drinks containing antiallergic component

#22193
20060115544
2006-06-01

Method and composition for the treatment of muscular-skeletal and related afflictions

#22194
20060115543
2006-06-01

Anti-diabetic extract isolated from and , and method of using same

#22195
20060115538
2006-06-01

Calcium lactate and whey permeate for lowering the triglyceride level

#22196
20060115537
2006-06-01

Nanoparticles for targeting hepatoma cells

#22197
20060115530
2006-06-01

Gastric acid secretion inhibiting composition

#22198
20060115520
2006-06-01

Fluid application device and method

#22199
20060115505
2006-06-01

SAFE, ECO-FRIENDLY, HEALTH PROTECTIVE HERBAL COLOURS AND AROMA USEFUL FOR COSMACEUTICAL APPLICATIONS

#22200
20060115500
2006-06-01

Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent